In a global landscape characterized by the growing menace of antibiotic resistance and increasing infection rates, the forecast for the global cephalosporin drugs market is promising. Estimations suggest that the global cephalosporin drugs market is set to reach a valuation of US$27.3 billion by 2034, up from $20.1 billion in 2024 at a compounded annual…